Press Releases

NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District, Chongqing were brought by Cho

TORONTO, Feb. 6, 2020 /PRNewswire/ -- Field Trip Psychedelics Inc. ("Field Trip" or the "Company"), the world's first mental wellness company focused exclusively on psychedelics and psychedelic-enhanced psychotherapy, is pleased to announce the closing of its oversubscribed Series A financing round. The financing, which was completed through a private

CHICAGO, Feb. 6, 2020 /PRNewswire/ -- Fueled by the growing demand for seasoned consulting expertise, EVERSANA™, the leading independent provider of commercial services to the life sc

HOUSTON, Feb. 6, 2020 /PRNewswire/ -- Angela A. Shippy, M.D., FACP, FHM, a tenured member of Memorial Hermann Health System's senior leadership team, has taken on an expanded role with her recent promotion to Chief Medical Officer. 

NEW YORK, Feb. 6, 2020 /PRNewswire/ -- The fourth annual Blue Jacket Fashion Show was held February 5, 2020 at Pier59 Studios, wrapping up CFDA's New York Men's Fashion Week. Janssen Oncology, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, returned as the official healthcare sponsor. The Blue Jacket Fashion Show was held to raise awareness f

SECAUCUS, N.J., Feb. 6, 2020 /PRNewswire/ -- The Vitamin Shoppe®, an omni-channel specialty retailer of nutritional products, announced today the launch of a premium sport

VANCOUVER, Feb. 6, 2020 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) announced today it has completed the acquisition of intellectual property pertaining to the nano delivery of cannabinoids, including the foundational processin

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 6, 2020 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix" or the "Company"), a specialty pharmaceutical company, announced today the publication of the Company's Phase 3 studies FX2016-11 and FX2016-12 (Studies 11 & 12) in the Journal of the American Academy of Dermatology (JAAD). Studies 11 and

BOSTON, Feb. 6, 2020 /PRNewswire/ -- Blossom Innovations, LLC, a Boston-based emerging medical technology company specializing in dermatology, announces that its S3Inject platform was awarded the Innovation of the Year Award at the recent 2020 International Master Course on Aging Science (IMCAS) World Congress, held in

LAS VEGAS, Feb. 6, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease (PAD). PAD affects over